Open-Label Study to Evaluate the EULAR-RAID Score, Rheumatoid Arthritis Impact of Disease Score, in Rheumatoid Arthritis Patients Eligible to Etanercept and Who Will Receive Etanercept.

Trial Profile

Open-Label Study to Evaluate the EULAR-RAID Score, Rheumatoid Arthritis Impact of Disease Score, in Rheumatoid Arthritis Patients Eligible to Etanercept and Who Will Receive Etanercept.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2014

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms Rainbow
  • Sponsors Wyeth
  • Most Recent Events

    • 22 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jan 2009 Actual initiation date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 24 Nov 2008 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top